Joe Eron Disclosures made as part of an online Continuing Medical Education program he participated in 07/05: Joseph J. Eron, Jr, MD, has received grants or research support from: Merck & Co. Vitex (also known as V.I. Technologies, Inc. and currently known as Panacos Pharmaceuticals, where the AACTG's Dr. Jeffery Jacobson serves on the company's Scientific Advisory Board) He has served as a paid consultant to: Abbott Laboratories Boehringer-Ingelheim Bristol-Myers Squibb GlaxoSmithKline Tibotec-Virco In a 12/05 paper in the Journal of Acquired Immune Deficiency Syndromes (JAIDS 2005;40(4):404-412), Dr. Eron disclosed that he had worked as a paid consultant to Roche and Trimeris and that his institution (University of North Carolina - Chapel Hill) had received funding from these companies. March 2005 disclosures: Joseph J. Eron Jr, MD Associate Professor of Medicine University of North Carolina School of Medicine University of North Carolina Associate Director, Clinical Research Unit Director, AIDS Clinical Trial Unit Chapel Hill, North Carolina Dr. Eron serves as a consultant for Abbott, Boehringer Ingelheim, GlaxoSmithKline, Merck , Roche, Tibotec, and Trimeris. Source: CME program, “Investigational Protease Inhibitor: Role of Tipranavir,” at imedoptions.com (URL: http://www.clinicaloptions.com/hiv/treatment/switching/ Accessed 03-01-05)